Nema internetske veze — prikazuje se spremljena verzija stranice.

bioAffinity Techn…

USUSD
← Na Filtar Dionica

bioAffinity Technologies, Inc. (US:BIAF) — Biotechnology: Commercial Physical & Biological Resarch. Broj burzi na kojima se trguje dionicama tvrtke: 1. Na ovoj stranici — cijena i grafikon, dividende, najveći dioničari i povijest broja dionica.

O Tvrtki

Web-Stranica
bioaffinitytech.com
Odnosi s Investitorima
bioaffinitytech.com/contact/
Sektor
Health Care · Biotechnology: Commercial Physical & Biological Resarch
Sjedište
SAN ANTONIO, United States
Glavni Direktor
Maria Zannes
Zaposlenici
57
Dionice u Optjecaju
8.1 mil. na dan 2026-08-03
Slobodno Prenosive Dionice
532 257
Tržišna Kapitalizacija
3.69 mil. USD
Insajderi
0.82%
Institucionalni Ulagači
5.62%
Djelatnost (SIC)
Services-Commercial Physical & Biological Research
P/E
gubitak
FCF
−11.6 mil. USD
Dug
36.5 tis. USD
neto novac
Zarada i FCF — za 12 mjeseci do 30.06.2026 (najnovije izvješće tvrtke).
NAV
0.56 USD · P/NAV 6.32
Datum Bilance30.06.2026
Imovina7.62 mil. USD
− Obveze3.85 mil. USD
= NAV (Kapital Dioničara Tvrtke)3.77 mil. USD
− Goodwill1.40 mil. USD
− Nematerijalna Imovina688 tis. USD
= Materijalna NAV1.68 mil. USD
Dionice6 783 061
NAV po Dionici0.56 USD
Opipljivi NAV po Dionici0.25 USD
Cijena Dionice (BIAF)3.5100 USD
P/NAV6.32
Povijest NAV-a
Datum BilanceNAVNAV po Dionici
30.06.20263.77 mil. USD0.56 USD
31.03.20263.65 mil. USD0.81 USD
31.12.20257.28 mil. USD1.62 USD
30.09.20258.90 mil. USD2.57 USD
30.06.2025−2.14 mil. USD−0.08 USD
31.03.20251.44 mil. USD0.08 USD
31.12.20242.60 mil. USD5.01 USD
30.09.20243.12 mil. USD0.23 USD
Opis

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. The company has a collaboration with Brooke Army Medical Center to evaluate its proprietary tests under development to identify inflammatory biomarkers for asthma and chronic obstructive pulmonary disease. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.

oglas

Burze i Oznake

BurzaOznakaValutaCijenaVrsta
US USA StocksBIAFUSD3.51 -5.90%obične dionice

Cijena za 3 Mjeseca

US:BIAF · USD
dan rasta dan padaPrijeđite mišem / dodirnite dan — cijene otvaranja, zatvaranja, najviša i najniža

Vijesti Ovog Tjedna

Priopćenja za medije s web stranice za investitore tvrtke, ažurirana svakodnevno. Poveznice vode na web stranicu tvrtke. Naslovi su na izvornom jeziku, kao na web stranici tvrtke.

Najveći Imatelji

ImateljUdioDioniceDatum Izvješća
ZANNES MARIA (Chief Exec…≈46.94%280 3592025-01-10
EDWARDS JAMES MICHAEL CP…≈20.11%120 1282025-01-10
ZANNES TIMOTHY PETER (Ge…≈9.17%54 7652025-01-10
REVELES XAVIER TRINIDAD…≈7.02%41 9432025-01-10
Sabby Management, LLC4.06%24 3772026-06-30
Blackrock Inc.1.1%6 5852026-06-30
Vanguard Capital Managem…0.62%3 7032026-06-30
VANGUARD INDEX FUNDS-Van…0.62%3 7032026-06-30
Geode Capital Management…0.57%3 3982026-06-30
J. Safra Sarasin Holding…0.47%2 8402026-06-30
Vanguard Fiduciary Trust…0.34%2 0712026-06-30
Susquehanna Internationa…0.3%1 7912026-06-30
Jane Street Group, LLC0.3%1 7862026-06-30
Fidelity Concord Street…0.28%1 6592026-07-31
State Street Corporation0.27%1 6062026-06-30
HRT Financial LP0.23%1 3892026-06-30
Fidelity Concord Street…0.08%5092026-07-31
Fidelity Concord Street…0.07%4342026-07-31
Fidelity Concord Street…0.03%1672026-07-31
GIRGENTI STEVEN (Officer…—1.09 mil.2025-01-10